Brian E. Mcdowell

Array ( [id] => 285538 [patent_doc_number] => 07550465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them' [patent_app_type] => utility [patent_app_number] => 11/753207 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 8 [patent_no_of_words] => 16229 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550465.pdf [firstpage_image] =>[orig_patent_app_number] => 11753207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910277 [patent_doc_number] => 20080021044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'N-[2-[[(DIAMINOMETHYLENE)AMINO]OXY]ETHYL]-3-[(2,2-DIFLUORO-2-PHENYLETHYL)AMINO]-6-METHYL-2-OXO-1(2H)-PYRAZINEACETAMIDE' [patent_app_type] => utility [patent_app_number] => 11/751155 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15777 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021044.pdf [firstpage_image] =>[orig_patent_app_number] => 11751155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670421 [patent_doc_number] => 20080045481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'NOVEL CO-CRYSTAL' [patent_app_type] => utility [patent_app_number] => 11/748651 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15287 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045481.pdf [firstpage_image] =>[orig_patent_app_number] => 11748651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4509070 [patent_doc_number] => 07915409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Organometal complex and light-emitting element using the same' [patent_app_type] => utility [patent_app_number] => 11/797532 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10795 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915409.pdf [firstpage_image] =>[orig_patent_app_number] => 11797532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228903 [patent_doc_number] => 07601716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors' [patent_app_type] => utility [patent_app_number] => 11/799066 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84793 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601716.pdf [firstpage_image] =>[orig_patent_app_number] => 11799066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896737 [patent_doc_number] => 08476258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same' [patent_app_type] => utility [patent_app_number] => 12/298564 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5069 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12298564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029143 [patent_doc_number] => 20070270590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'METHODS FOR PREPARING ESZOPICLONE CRYSTALLINE FORM A, SUBSTANTIALLY PURE ESZOPICLONE AND OPTICALLY ENRICHED ESZOPICLONE' [patent_app_type] => utility [patent_app_number] => 11/738115 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5715 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270590.pdf [firstpage_image] =>[orig_patent_app_number] => 11738115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211031 [patent_doc_number] => 20070249615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Pyridine [3,4-b] Pyrazinones' [patent_app_type] => utility [patent_app_number] => 11/737966 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33209 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249615.pdf [firstpage_image] =>[orig_patent_app_number] => 11737966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222814 [patent_doc_number] => 20100056506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/299381 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55279 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056506.pdf [firstpage_image] =>[orig_patent_app_number] => 12299381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445021 [patent_doc_number] => 20100144693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)' [patent_app_type] => utility [patent_app_number] => 12/297165 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19127 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144693.pdf [firstpage_image] =>[orig_patent_app_number] => 12297165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225628 [patent_doc_number] => 20070254895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Crystalline solvate of glucokinase activator' [patent_app_type] => utility [patent_app_number] => 11/786309 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10382 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254895.pdf [firstpage_image] =>[orig_patent_app_number] => 11786309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247895 [patent_doc_number] => 20070244129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Process for the preparation of an isopropanol solvate of a glucokinase activator' [patent_app_type] => utility [patent_app_number] => 11/786269 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7912 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244129.pdf [firstpage_image] =>[orig_patent_app_number] => 11786269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595424 [patent_doc_number] => 20100048561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'QUINAZOLINES FOR PDK1 INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/295967 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38141 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048561.pdf [firstpage_image] =>[orig_patent_app_number] => 12295967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436262 [patent_doc_number] => 20090170849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'QUINAZOLINONE DERIVATIVES HAVING B-RAF INHIBITORY ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/295825 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12584 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170849.pdf [firstpage_image] =>[orig_patent_app_number] => 12295825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257526 [patent_doc_number] => 20100029671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders' [patent_app_type] => utility [patent_app_number] => 11/922913 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26350 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029671.pdf [firstpage_image] =>[orig_patent_app_number] => 11922913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063050 [patent_doc_number] => 20070224690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'VARENICLINE STANDARDS AND IMPURITY CONTROLS' [patent_app_type] => utility [patent_app_number] => 11/691061 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5082 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224690.pdf [firstpage_image] =>[orig_patent_app_number] => 11691061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658361 [patent_doc_number] => 20080027223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'POLYMORPHS OF ESZOPICLONE MALATE' [patent_app_type] => utility [patent_app_number] => 11/690580 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4334 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027223.pdf [firstpage_image] =>[orig_patent_app_number] => 11690580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33188 [patent_doc_number] => 07790884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Acylaminopiperidine compound' [patent_app_type] => utility [patent_app_number] => 12/294145 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9043 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790884.pdf [firstpage_image] =>[orig_patent_app_number] => 12294145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534197 [patent_doc_number] => 07872031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'c-MET protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/726170 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69639 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872031.pdf [firstpage_image] =>[orig_patent_app_number] => 11726170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5060737 [patent_doc_number] => 20070222374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative' [patent_app_type] => utility [patent_app_number] => 11/723385 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 30532 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20070222374.pdf [firstpage_image] =>[orig_patent_app_number] => 11723385 [rel_patent_id] =>[rel_patent_doc_number] =>)